𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diabetes mellitus and major depressive disorder: An overview of prevalence, complications, and treatment

✍ Scribed by Caroline Carney


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
95 KB
Volume
7
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prevalence and patterns of major depress
✍ Dave E. Marcotte; Virginia Wilcox-GΓΆk; D. Patrick Redmon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Background and Aims of the Study: In this paper, we identify the 12-month and lifetime prevalence of major depressive disorder in and out of the labor force, and among the employed and unemployed. We examine whether prevalence by labor force and employment status varies by gender and over the l

Risk factors, pregnancy complications, a
✍ Baha M. Sibai πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## Objective: To review the rate, risk factors, and potential prevention of preeclampsia in women with pregravid diabetes mellitus. ## Methods: Detailed review of recent english literature describing pregnancy outcome in women with pregravid insulin-dependent diabetes mellitus (type 1 diabetes).

Prevalence of diabetes mellitus and asso
✍ J.T. Jimenez; M. Palacios; F. CaΓ±ete; L.A. Barriocanal; U. Medina; R. Figueredo; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

A cross-sectional study was conducted on a 20-74-year-old population in an urban white-Hispanic population in Paraguay to determine the prevalence of diabetes mellitus (DM), impaired glucose tolerance (IGT), and associated cardiovascular disease (CVD) risk factors. In total 1606 subjects completed t

The influence of trazodone treatment on
✍ Wim J. Riedel; Els Schoenmakers; Annemiek Vermeeren; James F. O'Hanlon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 2 views

Eight patients suering from major depression were treated with trazodone 150 or 200 mg bid (non-responders) over 5 weeks, preceded and followed by a placebo week. Cognitive functioning was tested in the morning at the end of each treatment week. Before trazodone treatment commenced, patients' cognit